Northern Trust’s Elevation Oncology ELEV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33.4K | Sell |
90,912
-367,552
| -80% | -$135K | ﹤0.01% | 4295 |
|
|
2025
Q1 | $119K | Buy |
458,464
+25,844
| +6% | +$6.7K | ﹤0.01% | 4076 |
|
|
2024
Q4 | $243K | Buy |
432,620
+59,392
| +16% | +$33.4K | ﹤0.01% | 3914 |
|
|
2024
Q3 | $224K | Buy |
373,228
+276,169
| +285% | +$166K | ﹤0.01% | 3846 |
|
|
2024
Q2 | $262K | Buy |
97,059
+32,261
| +50% | +$87.1K | ﹤0.01% | 3760 |
|
|
2024
Q1 | $332K | Buy |
64,798
+20,264
| +46% | +$104K | ﹤0.01% | 3710 |
|
|
2023
Q4 | $23.9K | Hold |
44,534
| – | – | ﹤0.01% | 4341 |
|
|
2023
Q3 | $29.5K | Buy |
44,534
+29,543
| +197% | +$19.6K | ﹤0.01% | 4264 |
|
|
2023
Q2 | $22.8K | Hold |
14,991
| – | – | ﹤0.01% | 4384 |
|
|
2023
Q1 | $28.5K | Buy |
+14,991
| New | +$28.5K | ﹤0.01% | 4378 |
|
|
2022
Q1 | – | Sell |
-2,295
| Closed | -$14K | – | 4769 |
|
|
2021
Q4 | $14K | Buy |
+2,295
| New | +$14K | ﹤0.01% | 4728 |
|
|
2021
Q3 | – | Sell |
-4,803
| Closed | -$65K | – | 4677 |
|
|
2021
Q2 | $65K | Buy |
+4,803
| New | +$65K | ﹤0.01% | 4443 |
|